Omacor® is a new medication that consists of a high concentration of highly purified omega-3 fatty acid ethyl esters. Approved by the Food and Drug Administration in November 2004, this new drug is used to treat hypertriglyceridemia and is meant to serve as an adjunctive therapy in addition to healthy eating habits, and the control of heart disease risk factors, such as high blood pressure, diabetes, and high cholesterol levels. Hypertriglyceridemia is a condition in which triglyceride levels exceed 500 mg/dL and could be a precursor to serious heart disease if not properly addressed. This medication, which is manufactured by Pronova Biocare and Reliant Pharmaceuticals, was released on the US market in the fall of 2005.
2007-07-13
16:44:20
·
7 answers
·
asked by
Anonymous
in
Health
➔ Diseases & Conditions
➔ Heart Diseases